Cardiac MRI

Researchers found that non-contrast head CT exams, head and neck CT exams and spine CT imaging increased by 33 percent, 76.9 percent and 52.9 percent, respectively, per 1,000 emergency department encounters over the last decade.

Catch up on the most well-viewed video interviews from Diagnostic Imaging in May 2026.

Increased paraspinal intermuscular adipose tissue (IMAT) on whole-body MRI was associated with a 67 percent higher likelihood of hypertension, according to new research involving over 11,300 participants without preexisting conditions.

Catch up on the most-well viewed radiology content in April 2026.

Catch up on a variety of new FDA clearances in radiology from the past week.

Employing the SwiftMR software with deep learning reconstruction solutions from original equipment manufacturers (OEMs) may provide additional sequence coverage as well as scan time reduction.

Catch up on the top radiology content of the past week.

For patients with cardiac dysfunction related to neoadjuvant chemotherapy for invasive breast cancer, new MRI research shows increased risks for concurrent decreases in total brain volume and white matter volume.

In an interview, W. Taylor Kimberly, M.D., discussed recent research showing that multidirectional diffusion-weighted imaging (DWI) on low-field MRI yielded a 95 percent positive predictive value (PPV) for detecting acute ischemic stroke.

Catch up on a variety of new FDA clearances and approvals in radiology from the past week.

Reportedly providing automation of 14 standard and advanced cardiac MRI views in less than 30 seconds, the SmartHeart also facilitates a 75 percent reduction in breath holds for basic MRI views.

Catch up on a variety of new FDA clearances and approvals in radiology from the past week.

The MEDRAD MRXperion MR Injection System is cleared for use with low-field and high-field MRI platforms, including 7T MRI.

Catch up on a variety of new FDA clearances and approvals in radiology from the past week.

Catch up on the top radiology content of the past week.

Previously approved by the FDA in 2022, the macrocyclic gadolinium-based MRI contrast agent gadopiclenol can now be utilized to detect lesions with abnormal vascularity in the central nervous system and other parts of the body for children under the age of two.

The FDA clearances include the 1.5T SIGNA Sprint with Freelium MRI platform, the 3T SIGNA Bolt MRI system and the AI-powered SIGNA One, which reportedly enhances MRI workflow efficiencies.

A machine learning model incorporating cardiac MRI and clinical data provided a 91 percent AUC for predicting major adverse cardiovascular events (MACE) in patients with STEMI, according to a new study involving over 1,000 patients and a median follow-up of 40 months.

Catch up on a variety of new FDA clearances in radiology from the past week.

The Ascent3T Neonatal Magnetic Resonance Imaging System is reportedly the first high-field 3T system geared to neonatal applications.

The Biograph One PET/MRI system may facilitate accelerated scan times, improved visualization and more efficient assessments of theranostic approaches for patients with oncologic and neurological diseases.

Employing latent profile analysis (LPA) to help assess body fat distribution patterns, researchers found that a pancreatic-predominant profile with elevated proton density fat fraction derived from MRI was associated with extensive gray matter atrophy and cognitive decline.

Catch up on the most well-viewed MRI content from 2025.

Catch up on the top radiology content of the past week.

The multi-directional diffusion-weighted imaging (DWI) sequence reportedly bolsters small stroke detection and infarct differentiation for portable MRI of the brain.